Impact of Radiation Therapy on Breast Conservation in DCIS
Completed
Conditions studied: DCIS
In brief
Large regional variation exists in the use of radiotherapy after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Although patients who do not receive initial radiotherapy for DCIS are candidates for subsequent BCS if they experience a second breast event, many undergo mastectomy instead.
Key facts
- Study ID
- NCT02248662
- Run by
- Dana-Farber Cancer Institute
- People needed
- 3436
- Starts
- 2013-08-01
- Expected to finish
- 2017-01-01
- Last updated by the study team
- 2019-09-06
Who can join
Age: 21 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Harvard Pilgrim Health Care Institute — Boston, Massachusetts, United States
- Dartmouth College — Hanover, New Hampshire, United States
- University of Wisconsin — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.